Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Emerging Healthcare Inc. Acquires China Rights to Stem Cell Technology

publication date: Dec 30, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Emerging Healthcare Solutions, Inc. of Houston has in-licensed the China rights to a system from Regenetech that cultures stem cells in a simulated weightless environment. Regenetech’s Intrifuge™ Rotary Cell Culture System was developed by NASA and licensed to Regenetech. EHSI plans to combine the stem cell culturing technology with a treatment for liver disease. More details....

Stock Symbol: (OTCPK: EHSI)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors